|
Oncogene
|
|
|
25 September 1997, Volume 15, Issue 13, Pages 1535 – 1544 |
![]() |
|
Journal Home |
||
| <- Previous | Issue Contents | Next -> |
| Article |
|
Transcriptional regulation of OCI-5/Glypican 3: elongation control of confluence-dependent induction
M Li1,4, R Pullano1, HL Yang2, HK Lee1, NG Miyamoto3, J Filmus2 & RN Buick5 1Ontario Cancer Institute/Princess Margaret Hospital and Department of Medical Biophysics, University of Toronto, 610 University Ave. Tononto, M5G 2M9 2Division of Cancer Research, Sunnybrook Health Science Centre and Department of Medical Biophysics, University of Toronto, Toronto, Canada 3Department of Immunology, Berlex Biosciences, 15049 San Pablo Avenue, Richmond, California 94804, USA4Author for correspondence 5Deceased July 20, 1996 |
| Keywords |
| proteoglycan;
SGBS;
intestine;
promoter;
elongation;
confluence |
| Abstract |
OCI-5/Glypican 3, a member of the glypican family of proteoglycans, is the defective gene in the Simpson-Golabi-Behmel overgrowth syndrome. OCI-5 expression is developmentally regulated in the intestinal epithelium, and the mechanism of its regulation was studied in the rat intestinal epithelial cell line IEC-18. A large induction of OCI-5 transcript and protein was observed at high cell density. Among other glypican family members, |
Received 20 November, 96; Revised 2 June, 97; Accepted 2 June, 97